AN2 Therapeutics, Inc.'s total assets for Q2 2024 were $108.48M, a decrease of -10.54% from the previous quarter. ANTX total liabilities were $10.13M for the fiscal quarter, a -5.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.